free hit counters
French Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Ipsen receives positive opinion in Europe for Dysport® in the management of urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury

Read more ››
By: GlobeNewswire - 09 Jun 2023
Related companies:  Ipsen SA

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Valneva SE

Enterome announces sustained positive clinical outcomes with EO2401, its lead OncoMimics™ immunotherapy, in combination therapy in Glioblastoma at ASCO

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Enterome S.A.

Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Coave Therapeutics

SGS receives WHO-PQT approval for its Navi Mumbai laboratory, bolstering support to the global pharma industry

Read more ››
By: PR Newswire Association LLC. - 31 May 2023

Merck Study: mRNA Technology a 'Game Changer' for Asia-Pacific Vaccine Manufacturers

Read more ››
By: PR Newswire Association LLC. - 31 May 2023

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

Read more ››
By: PR Newswire Association LLC. - 31 May 2023

Valneva Announces the Availability of Documentation for its Shareholder Meeting

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Valneva SE

Ipsen - Description of the regulatory framework of the share repurchase program to be approved at the Combined Shareholders’ Meeting on 31 May 2023

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Ipsen SA

Press Release: Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis

Read more ››
By: GlobeNewswire - 31 May 2023
Related companies:  Sanofi SA

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

Read more ››
By: PR Newswire Association LLC. - 31 May 2023

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 30 May 2023

SS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones

Read more ››
By: GlobeNewswire - 30 May 2023

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

Read more ››
By: PR Newswire Association LLC. - 30 May 2023

DEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER

Read more ››
By: PR Newswire Association LLC. - 30 May 2023

Valneva Files for Chikungunya Vaccine Authorization with Health Canada

Read more ››
By: GlobeNewswire - 30 May 2023
Related companies:  Valneva SE

Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Read more ››
By: PR Newswire Association LLC. - 29 May 2023

ABIOGEN PHARMA COMPLETES THE ACQUISITION OF EFFRX

Read more ››
By: PR Newswire Association LLC. - 29 May 2023

Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023

Read more ››
By: GlobeNewswire - 26 May 2023
Related companies:  Inventiva Pharma

Ipsen receives CHMP negative opinion, following re-examination of potential first FOP treatment in the E.U.

Read more ››
By: GlobeNewswire - 26 May 2023
Related companies:  Ipsen SA
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of France?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • June 2023
    • Boston: Product & Company Valuation Course
    • BIO International Convention 2023
    • RESI Boston
See Events »
Add an Event »

Latest company news

Ipsen receives positive opinion in Europe for Dysport® in the management of urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury
09 Jun 2023 (GlobeNewswire)

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
31 May 2023 (GlobeNewswire)

Enterome announces sustained positive clinical outcomes with EO2401, its lead OncoMimics™ immunotherapy, in combination therapy in Glioblastoma at ASCO
31 May 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The French Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com